Videos of Dr Crispin Hiley
In this fascinating and revealing introductory video, highly esteemed consultant clinical oncologist, Dr Crispin, tells us what the most rewarding aspect of his profession is, and what he believes his patients value most about him. Book a consultation with Dr Hiley by visiting his Top Doctors profile here today: https://www.topdoctors.co.uk/doctor/crispin-hiley ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh
In one of our latest online interviews, Dr Crsipin Hiley, a highly revered consultant clinical oncologist, explains what proton therapy is, and what types of cancer it is generally used to treat. 00:00 Introduction 00:08 What is proton therapy? 01:31 What types of cancer can be treated with proton therapy? 03:00 How does proton therapy compare to other approaches to cancer treatment? 04:09 What are the potential side effects of proton therapy? 05:05 When is proton therapy indicated for patients with lung cancer? 06:43 How can it benefit patients with non-small cell lung cancer? 10:08 Can it benefit patients with a thymoma? 11:15 In what ways can it benefit patients with mesothelioma? To book a consultation with Dr Hiley, you can visit his Top Doctors profile here today: https://www.topdoctors.co.uk/doctor/c... ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh
Radiotherapy can be used to destroy tumours, to shrink tumours before surgery, or to kill off remaining cancer cells after surgery or chemotherapy. It is also used to treat the symptoms and control the spread of cancer. At Cromwell Hospital, we are fully equipped to diagnose and treat a diverse range of cancers including complex cases. www.cromwellhospital.com/services-specialties/integrated-cancer-campus/
Immunotherapy is a form of treatment that helps the immune system recognise and destroy cancer cells. At Cromwell Hospital, we provide the very latest cancer treatments, including chemotherapy, radiotherapy, immunotherapy, robotic surgery and more – all delivered by our world-leading oncologists and highly trained healthcare professionals. www.cromwellhospital.com/services-specialties/integrated-cancer-campus/
Our one-stop Full Lung Health Check and Lung Cancer Check provides a comprehensive assessment of your lung health, delivered by a team of world-class respiratory experts. Our Integrated Cancer Campus offers rapid access to diagnosis and treatment, including advanced therapies and specialised follow-up care for all cancers. From first consultation to follow-up care, we are with you throughout your cancer journey. Find out more about our Lung Health Check: https://www.cromwellhospital.com/serv... Find out more about our Integrated Cancer Campus: https://www.cromwellhospital.com/serv...
Our one-stop Full Lung Health Check and Lung Cancer Check provides a comprehensive assessment of your lung health, delivered by a team of world-class respiratory experts. At Cromwell Hospital, we provide the very latest cancer treatments, including chemotherapy, radiotherapy, immunotherapy, robotic surgery and more – all delivered by our world-leading oncologists and highly trained healthcare professionals. Find out more about our Lung Health Check: https://www.cromwellhospital.com/serv... Find out more about our Integrated Cancer Campus: https://www.cromwellhospital.com/serv...
Crispin Hiley, PhD, UCL Cancer Institute, London, UK, shares an overview of the Phase II DARWIN II trial (NCT02314481), a multicenter, molecularly stratified trial designed to investigate how intratumor heterogeneity influences treatment response in patients with NSCLC. The DARWIN II trial enrolled 65 patients with metastatic NSCLC who had previously participated in the TRACERx Lung Cancer observational cohort study. They received atezolizumab or atezolizumab with chemotherapy. Multi-omic analysis of primary tumor and relapse biopsies revealed that a high clonal mutation burden was associated with a significantly improved response. Novel molecular features, including intratumor heterogeneity of the transcriptome and DNA methylation, were also linked to immunotherapy response. This study marks the first to prospectively show that clonal mutations and specific molecular features can predict immunotherapy outcomes in patients with NSCLC. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
In this revealing online interview, Dr Crispin Hiley, a revered London-based consultant clinical oncologist, reveals what the most common causes of lung cancer are, and details the newest lung cancer treatment options that have recently become available. 00:00 What are the main early warning signs of lung cancer? 01:28 Can you detail the newest treatment options available for lung cancer? 03:10 How is it diagnosed? 05:12 What are the known causes of lung cancer? 06:37 How does/can lung cancer affect one’s daily life? 07:38 How is lung cancer treated and what are the chances of survival through these various treatment options? To book a consultation with Dr Hiley, simply go to his Top Doctors profile here today: https://www.topdoctors.co.uk/doctor/crispin-hiley ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh